Literature DB >> 6498856

Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trial.

J J Kavanagh, J T Wharton, F N Rutledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6498856

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.

Authors:  R H Earhart; J D Khandekar; D Faraggi; R A Schinella; T E Davis
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

2.  cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.

Authors:  A P Wilson; C H Ford; C E Newman; A Howell
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.